PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer

Abstract Background PAX1 gene methylation plays an important role in the development of cervical cancer. However, its prognostic value after radiotherapy for locally advanced cervical cancer is unknown, so this study aimed to investigate the value of PAX1 gene methylation for predicting the sensitiv...

Full description

Bibliographic Details
Main Authors: Xuanxuan Li, Huan Liu, Xue Zhou, Yangying Zhou, Yu Zhang, Yu-Ligh Liou, Manting Zeng, Hong Zhu
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Clinical Epigenetics
Subjects:
PAX1
Methylation
Cervical cancer
Radioresistance
Online Access:https://doi.org/10.1186/s13148-023-01538-1

Similar Items

Similar Items